Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors
Shares of Becton Dickinson & Co. BDX slipped 1.60% to $225.85 Wednesday, on what proved to be an all-around rough trading ...
Citi Sticks to Its Buy Rating for Becton Dickinson (BDX)
Citi analyst Joanne Wuensch maintained a Buy rating on Becton Dickinson (BDX – Research Report) today. The company’s shares closed last Friday ...
Barclays Remains a Buy on Becton Dickinson (BDX)
Barclays analyst Matt Miksic maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $278.00. The ...
Starboard pushes an open door at Becton Dickinson as company seeks to separate its biosciences unit
Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...
Yahoo Finance6d
Q1 2025 Becton Dickinson and Co Earnings Call
Greg Rodetis; Senior Vice President, Treasurer and Head of Investor Relations; Becton Dickinson and Co Thomas Polen; Chairman of the Board, President, Chief Executive Officer; Becton Dickinson and ...
Yahoo Finance6d
Becton Dickinson price target raised to $269 from $265 at BofA
Becton Dickinson Announces Strategic Business Separation Plan BD sees FY25 adjusted EPS $14.30-$14.60 vs. previous view $14.25-$14.60 Becton Dickinson to separate biosciences, diagnostic solutions ...
NBC Los Angeles5d
Starboard pushes an open door at Becton Dickinson as company seeks to separate its biosciences unit
Business: Becton Dickinson develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products for health-care institutions, physicians, life science ...
NBC New York5d
Starboard pushes an open door at Becton Dickinson as company seeks to separate its biosciences unit
Becton Dickinson (BDX) is a global medical technology company comprised of essentially two businesses: (i) MedTech, which consists of the BD Medical (medication delivery and management solutions ...